"
Team:SupBiotech-Paris/Bibliography
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 27: | Line 27: | ||
|height=40px|Current Therapies | |height=40px|Current Therapies | ||
|[1] | |[1] | ||
| - | | | + | |Kevin J. Scanlon and al. |
| - | | | + | |Cancer Gene Therapy: Challenges and Opportunities |
| - | | | + | |2004 |
|- style="background: #C0C0C0; text-align: center;" | |- style="background: #C0C0C0; text-align: center;" | ||
|height=40px|Gene Therapies | |height=40px|Gene Therapies | ||
|[2] | |[2] | ||
| - | | | + | |Gouze JN and al. |
| - | | | + | |A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer |
| - | | | + | |2003 |
|- style="background: white; text-align: center;" | |- style="background: white; text-align: center;" | ||
Revision as of 12:29, 20 October 2009
Project
Introduction Current therapies Gene therapies DVS Concept Tissue Vector Cell Vector Therapeutic plasmid Conclusion Implementation Tissue targeting Antitumor action Treatment modeling Conclusion
Ressources
BioBricks Material & Method Bibliography
Ethics & Safety
| Chapitre | Ref. | Auteurs | Titre | Lien |
| Current Therapies | [1] | Lechat P. | Pharmacology | 2006 |
| Current Therapies | [2] | Bruguerolle B. | Biological rhythms and medications: a source of variability often neglected in pharmacology | 2008 |
| Current Therapies | [1] | Kevin J. Scanlon and al. | Cancer Gene Therapy: Challenges and Opportunities | 2004 |
| Gene Therapies | [2] | Gouze JN and al. | A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer | 2003 |
| Gene Therapies | [3] | Centre for Genetics Education | http://www.genetics.com.au/index.asp | XXXX |
| Vectorization | [1] | |||
| Vectorization | [2] | |||
| Vectorization | [3] | |||
| Vectorization | [4] | |||
| Vectorization | [5] | |||
| Vectorization | [6] | |||
| Vectorization | [7] | |||
| Vectorization | [8] | |||
| Vectorization | [9] | |||
| Vectorization | [10] | |||
| Vectorization | [11] | |||
| Vectorization | [12] | |||
| Vectorization | [13] | |||
| Vectorization | [14] | |||
| Vectorization | [15] | |||
| Tissue Vector | [1] | Ronald S. and al. | Antimicrobial mechanisms of phagocytes and bacterial evasion strategies | 2009 |
| Tissue Vector | [2] | Clark B. Inderlied and al. | The Mycobacterium avium Complex | 1993 |
| Tissue Vector | [3] | Nisheeth Agarwal and al. | Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase | 2009 |
| Tissue Vector | [4] | Hunter R.L. and al. | Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs | 2007 |
| Tissue Vector | [5] | Axelrod S and al. | Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide | 2008 |
| Tissue Vector | [6] | Nicole N van der Wel and al. | Subcellular localization of mycobacteria in tissues and detection of lipid antigens in organelles using cryo-techniques for light and electron microscopy | 2005 |
| Tissue Vector | [7] | Claudia Nobrega and al. | The thymus as a target for mycobacterial infections | 2007 |
| Cell Vector | [1] | Harrison Echols and al. | Genetic Map of Bacteriophage Lambda | 1978 |
| Cell Vector | [2] | Joseph Sambrook and al. | Molecular Cloning: A Laboratory Manual (Third Edition) | 2001 |
| Cell Vector | [3] | Court DL and al. | A New Look at Bacteriophage lambda Genetic Networks | 2007 |
| Cell Vector | [4] | Ortega ME and al. | Bacteriophage Lambda gpNu1 and Escherichia coli IHF Proteins Cooperatively Bind and Bend Viral DNA: Implications for the Assembly of a Genome-Packaging Motor | 2006 |
| Cell Vector | [5] | Feiss M. and al. | Bactériophage Lambda Terminase and the Mechanism of Viral DNA Packaging | 2005 |
| Cell Vector | [6] | Hang JQ and al. | The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB | 2001 |
| Cell Vector | [7] | Becker A and al. | Bacteriophage lambda DNA : The begginning of the End | 1990 |
| Cell Vector | [8] | Hochschild A and al. | The bactériophage lambda cI protein finds an asymmetric solution | 2009 |
| Cell Vector | [9] | Phoebe L.Stewart1 and al. | Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization | 1997 |
| Therapeutic Plasmide | [1] | Ortega ME et al. | Bacteriophage lambda gpNu1 and Escherichia coli IHF proteins cooperatively bind and bend viral DNA: implications for the assembly of a genome-packaging motor | 2006 |
| Therapeutic Plasmide | [2] | Joseph Sambrook and al. | Molecular Cloning: A Laboratory Manual (Third Edition) | 2001 |
| Therapeutic Plasmide | [3] | Court DL and al. | A New Look at Bacteriophage lambda Genetic Networks | 2007 |
| Therapeutic Plasmide | [4] | Feiss M. and al. | Viral Genome Packaging Machines: Genetics, Structure and Mechanism | 2005 |
| Therapeutic Plasmide | [5] | Hang JQ and al. | The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB | 2001 |
| Therapeutic Plasmide | [6] | Becker A and al. | Bacteriophage lambda DNA : The begginning of the End | 1990 |
| Therapeutic Plasmide | [7] | Young et al. | Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature | 2003 |
| [] |
